CompuGroup stock holds steady as revenue stays at 1.25B
Published on 08/21/2026 at 10:56 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
CompuGroup Medical SE & Co. KGaA (DE000A288904) traded at EUR 27.50 in the latest snapshot, with a 52-week range of EUR 23.24 to EUR 29.00 and volume of 3,795 shares. The same snapshot puts trailing revenue at $1.25B and net income at $28.24M, with diluted EPS of 0.52.
What the quote shows
The latest quoted session closed at EUR 27.50 on July 31, 2026, while the share count in the snapshot stayed unchanged through a flat 0.00% move. Profitability metrics in the same data set show a 2.27% profit margin and 102.64M in levered free cash flow.
Latest reported picture
The most recent figures available in the source set are TTM values, so they describe a trailing picture rather than a fresh quarterly update. Revenue stood at 1.25B, net income at 28.24M, and total debt to equity at 124.97%, which keeps balance-sheet leverage part of the story.
Business mix
CompuGroup Medical runs e-health software across ambulatory, hospital, and pharmacy systems, with tools for practice management, clinical documentation, billing, and pharmacy workflow. That mix matters because the company still ties its revenue base to recurring software and service use rather than a single product cycle.
Price and setup
For investors, the key levels in the snapshot are clear: EUR 27.50 sits between the EUR 23.24 low and EUR 29.00 high in the 52-week range. The stock also showed an EPS of 0.52 on trailing figures and a price-to-earnings ratio of 52.88 in the latest quote set.
Investor relations
Company: CompuGroup Medical SE & Co. KGaA
ISIN: DE000A288904
Ticker: COP.HM
Exchange: Hamburg
Price (as of July 31, 2026): EUR 27.50
Sector / Industry: Health Information Services
Next earnings date:
